Trihexyphenidyl for Acute Life-Threatening Episodes Due to a Dystonic Movement Disorder in Rett Syndrome

Artemis D. Gika*, Elaine Hughes, Sushma Goyal, Matthew Sparkes, Jean-Pierre Lin

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)

    Abstract

    In Rett syndrome (RS), acute life-threatening episodes (ALTEs) are usually attributed to epilepsy or autonomic dysfunction but they can represent a movement disorder (MD). We describe three girls with RS who experienced ALTEs from an early age. These were long considered epileptic until video-EEG in Patients 1 and 3 revealed their non-epileptic nature. A primary dystonic mechanism was suspected and Patients 1 and 2 were treated with Trihexyphenidyl with significantly reduced frequency of the ALTEs. Patient 3 died before Trihexyphenidyl was tried. Trihexyphenidyl in RS patients with similar presentations can modify the dystonia and prevent ALTEs.

    Original languageEnglish
    Pages (from-to)385-389
    Number of pages5
    JournalMovement Disorders
    Volume25
    Issue number3
    DOIs
    Publication statusPublished - 15 Feb 2010

    Keywords

    • Rett syndrome
    • dystonia
    • epilepsy
    • acute life threatening episodes
    • trihexyphenidyl

    Fingerprint

    Dive into the research topics of 'Trihexyphenidyl for Acute Life-Threatening Episodes Due to a Dystonic Movement Disorder in Rett Syndrome'. Together they form a unique fingerprint.

    Cite this